Minister of State Pat Breen said he wished to 'warmly welcome Edwards Lifesciences to the region'
EDWARDS Lifesciences has announced that it is to locate a new plant in Mid-West with an investment totaling €80m and 600 jobs expected.
The US corporation, a leader in patient-focused innovations for structural heart disease and critical care monitoring, said this Monday morning that it has “chosen the Mid-West of Ireland for the location of a new plant to manufacture delivery components for its transcatheter heart valve therapies”.
Edwards is planning to hire approximately 60 people this year in various functions, such as production staff, engineering and professional management, to work at its initial site located in the Shannon Free Zone.
The company plans to complete a new, purpose-built manufacturing facility in the Mid-West of Ireland in 2020 that, once fully complete, it expects will employ approximately 600 people. Edwards said its investment in the project is expected to amount to approximately €80m.
“Today is a wonderful day as we mark this very significant regional investment. The arrival of Edwards Lifesciences is a vote of confidence in the Mid-West region as a destination for high-end medical technology manufacturers,” said Minister Heather Humphreys.
“It will provide even more opportunities for local residents and communities to grow and thrive. My department, through the IDA, is committed to supporting Edwards as it establishes operations in Ireland and as the company continues to develop its innovative heart valve technologies.”
Minister of State Pat Breen said: “On behalf of everyone in the Mid-West, I would like warmly welcome Edwards Lifesciences to the region. Their presence here serves to highlight the attractiveness of the region as a destination for progressive, innovation-driven companies.
“I would like to wish Edwards well in their future operations and assure them of our ongoing support.”
“The addition of a manufacturing location in Ireland is an element of Edwards’ global supply strategy to support future growth and reliability of supply, and continues the growth in employment Edwards has experienced both in the United States and around the world,” said Joe Nuzzolese, Edwards’ corporate vice president, global supply chain.
“Choosing this location included many considerations, but an important one is a talented workforce with experience in medical technology. We look forward to becoming an integral part of the local community through engagement and philanthropic support, and providing educational and professional opportunities for our employees.
“We are excited to welcome these new associates into Edwards, with the shared goal of serving more patients around the world by delivering high quality life-saving technologies.”
The company expects to begin hiring new employees in Shannon by June.
The announcement comes after Shannon Commercial Properties said that a €40 million investment in property at the Shannon Free Zone was to be accelerated due to the demand for commercial property in the region.
The company said that by year end it will have brought over 500,000 square feet of new or upgraded office, manufacturing and warehouse facilities to the market in the free zone over the last four years.